Focus On

New IP partner for Lenczner Slaght

Monday, January 18, 2021 @ 9:50 AM | By John Chunn


Lenczner Slaght announced that new partner Andrew Moeser has joined its intellectual property (IP) team.

According to the Toronto firm’s press release, Moeser is an experienced litigator with a passion for intellectual property disputes. He also possesses a master’s degree in biology and has worked as a co-ordinator of a phase III clinical trial.

“We are delighted to welcome Andrew to our strong and growing IP team,” said managing partner Tom Curry. “Andrew brings his wide experience and subject matter expertise in science, law and advocacy, to further enhance our ability to meet the demand for our services in solving complex IP legal problems.”

Moeser’s practice is focused on IP litigation. In patent matters, he has experience with industries such as pharmaceutical and biologics, information technology and oil and gas. In trademark, copyright and trade secret matters, he has represented clients in disputes relating to software, gaming and beauty products. He has also gained experience in commercial litigation relating to environmental contamination, and in regulated industries such as pharmaceuticals and renewable energy.

Moeser has represented clients before all levels of court in Ontario, the Federal Court and Federal Court of Appeal, and the Alberta Court of Appeal. He has also acted pro hac vice in proceedings in the United States and has extensive experience as part of international teams litigating large cross-border disputes.

He is also an adjunct professor at the University of Toronto Faculty of Law, where he supervises a legal clinic providing assistance to the Structural Genomics Consortium, a not-for-profit public-private partnership that engages in precompetitive basic science research to facilitate and enable the discovery of new medicines.